Quest Diagnostics Commences Tender Offer for Acquisition of Celera for $8 per Share

Quest Diagnostics Incorporated DGX announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the outstanding shares of common stock of Celera Corporation CRA for $8.00 per share in cash, without interest and less any required withholding taxes. The tender offer is being made pursuant to an Offer to Purchase, dated March 28, 2011, and in connection with the previously announced Agreement and Plan of Merger, dated March 17, 2011, by and among Quest Diagnostics, Spark Acquisition Corporation and Celera.